Results 151 to 160 of about 4,104 (188)

Cardiometabolic complications after Cushing's disease remission. [PDF]

J Endocrinol Invest
Tizianel I, Lizzul L, Mondin A, Voltan G, Mazzeo P, Scaroni C, Barbot M, Ceccato F.   +7 more
europepmc   +1 more source

Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial

Christoph E. Heilig, Christoph Heining, E. Gnutzmann, Sandra Roldan, L. Heiligenthal, Monika Sparber‐Sauer, D Hahn, Uta Dirksen, Rainer Hamacher, Anne Flörcken, Anne Thorwarth, Christoph K.W. Deinzer, Verena I. Gaidzik, Elke Pfaff, Daniel Hübschmann, Karin Arndt, Stefan M. Pfister, Hanno Glimm, Stefan Fröhling, Richard F. Schlenk   +19 more
openalex   +1 more source

The dual SSTR2/5 specific somatostatin analog, AP102, does not affect glucose metabolism in diabetic ZDF rats: a comparative 14-day infusion study versus pasireotide

, 2017
Adrian Daly, Mark Sumeray
openalex   +1 more source

Structural insights into somatostatin receptor 5 bound with cyclic peptides. [PDF]

Acta Pharmacol Sin
Li YG, Meng XY, Yang X, Ling SL, Shi P, Tian CL, Yang F.   +6 more
europepmc   +1 more source

Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature. [PDF]

Endocr J
Taki Y, Kono T, Matsuda T, Kozu R, Fujimoto M, Sakuma I, Hashimoto N, Horiguchi K, Higuchi Y, Tanaka T.   +9 more
europepmc   +1 more source

ATF6 inhibition suppresses the protective effects of pasireotide in human and bovine endothelial cells. [PDF]

Vasc Biol
Fakir S, Sarker MMR, Sigdel M, Barabutis N.   +3 more
europepmc   +1 more source

Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain. [PDF]

J Clin Med
Araujo-Castro M, García-Centeno R, González L, Hanzu FA, Orois A, Camara R, García MDO, Echarri AI, Gracia Gimeno P, Pascual-Corrales E, Biagetti B, Cardona A, González Molero I, Simo-Servat A, Guerrero Pérez F, Villar-Taibo R, Bernabéu I, Fajardo-Montañana C, Novo-Rodríguez C, Tenorio Jimenéz C, Calatayud M, Moure Rodríguez MD, Cordido F, Castro A, Valero LM, Paja Fano M, Goi J, Aulinas A, Abellán P, Iglesias P, Soto-Moreno A.   +30 more
europepmc   +1 more source